Company intelligence / Profile preview

Yuurea

Ownership: Private
Development stage: Commercial

Overview

Yuurea develops at-home urine test kits that allow users to monitor various aspects of their physical condition using urine samples. The company is part of the growing at-home diagnostics market, with products aimed at diabetes, drug/alcohol testing, UTI detection, pregnancy, obesity/ketosis monitoring, and general wellness. There are no clinical trial results as these are diagnostic devices rather than therapeutics.

Therapeutic areas: Metabolic DisordersInfectious DiseasesEndocrinologyOtherWomen's Health
Modalities: DeviceDigital health toolDiagnostic test kit
Industry: Consumable Medical Devices

Partnerships

Toyoda Gosei invested in Yuurea for innovation in at-home urine testing

Beyond the preview

Go deeper on Yuurea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuurea.

Explore the full profile